Mustang Bio

MBIO • NASDAQ • Stock Fundamentals

Mustang Bio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Manuel Litchman, with a market cap of $6.0M.

Market Cap$6.0M

Employees80.0

CEOManuel Litchman

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026

Next EarningsAug 18, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Mustang Bio

Mustang Bio (MBIO) has a market capitalization of $6.0M and trades on NASDAQ.

Mustang Bio has approximately 80 employees.